DoW Rare Cancers Resource and Community Development Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 17, 2026
- Amount
- Program total $5.6M
- Closes
- Nov 18, 2026 (in 63 days)
Similar opportunities open now
- DoW Rare Cancers Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 63 days
- DoW Rare Cancers Concept AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
- DoW Bone Marrow Failure, Resource Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
- DoW Kidney Cancer, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 12 days
- DoW Duchenne Muscular Dystrophy, Clinical/Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 2 days
Classification and identifiers
- Solicitation number
- HT942526RCRPRCDA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $5.6M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Research supporting this funding opportunity should fill one of the following major gaps: Lack of research and clinical resources, including patient tissues, cell and tumor models. Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings. Lack of infrastructure for sharing data and other resources. Lack of therapeutics and mechanistic research to inform treatment development. Dis...